Johnson & Johnson Launches First Daily Disposable Toric Contact Lens Designed to Deliver on the Specific Needs of Low and High Astigmatic Patients in United Kingdom and Ireland (UKI)
September 4, 2025 – Drug Delivery, Other, Pharmaceutical – Johnson & Johnson, astigmatism, daily disposable toric contact lenses
- World’s #1 Selling Contact Lens Brand ACUVUE Brings Pioneering Innovation For Astigmatic Patients, Providing Visual Clarity And Comfort
- The First Toric Lens to have an Optimised Design according to Cylinder Power.
4 September 2025 — Wokingham, UK — Today, Johnson & Johnson, a global leader in eye health, announced the launch of a new product for astigmatic patients in UKI – ACUVUE OASYS MAX 1-Day Contact Lenses for Astigmatism – the first contact lens to optimise toric design according to cylinder power to deliver on the complex needs of astigmatic patients. The lens offers exceptional comfort, clarity and stability for astigmatic patients, with enhanced stability for patients with high astigmatism.
Astigmatism affects about half of patients in at least one eye, making it one of the most common vision conditions. While a variety of contact lens options exist for astigmatic patients, many still face challenges – with one in four discontinuing lens wear in the first year due to issues such as blurred or poor vision and discomfort. Designed with modern life in mind, ACUVUE OASYS MAX 1-Day Contact Lenses for Astigmatism offer optimal performance across the cylinder range for exceptional clarity and comfort, intended to deliver a personalised fit based on the amount of astigmatism. As digital device use continues to rise across all age groups, contributing to digital eye strain and dry eye symptoms, these lenses also help to empower patients to see comfortably amid evolving digital lifestyles.
Patients currently lead modern lifestyles with heavy digital device usage which can lead to digital eye strain and dry eye symptoms, impacting comfort across all ages. There is a need to design interventions focused to help preserve ocular surface health and associated well-being.
“We see a clear unmet need in astigmatism across the region, and our goal has been to grow our ACUVUE OASYS MAX 1-Day portfolio to address it. With the introduction of this new toric lens, we’re proud to offer the first contact lens with patient-centric design to meet specific astigmatic patient needs. This reflects our deep commitment to delivering tailored solutions that provide exceptional all-day comfort, clarity and stability for patients as they navigate an increasingly digitally-demanding world, while empowering eye care professionals with a comprehensive set of tools to offer customised care,” said Jacqueline Henderson, President Vision EMEA, Johnson & Johnson.
About Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalised. Johnson & Johnson Vision Care, Inc., is a Johnson & Johnson Company. Visit: www.jnj.com/medtech.
